Particle.news

Download on the App Store

Madhya Pradesh Bans Coldrif After 48.6% DEG Found as Doctor Held in Child Deaths

A national team is probing a Sresan Pharmaceuticals batch tested with diethylene glycol.

Overview

  • Government testing in Chennai found Coldrif Batch SR-13 (Mfg May 2025, Exp Apr 2027) contained 48.6% diethylene glycol and declared the sample not of standard quality.
  • Madhya Pradesh ordered statewide seizure of Coldrif and other Sresan products after Tamil Nadu’s ban, with Kerala and Rajasthan imposing curbs or suspensions and Telangana issuing a public alert.
  • Police filed FIRs against Sresan Pharmaceuticals and paediatrician Praveen Soni; Soni was arrested and suspended as inquiries into alleged negligence and adulteration proceed.
  • The Union Health Ministry and CDSCO launched risk-based inspections of manufacturers in six states and convened an urgent meeting of state health and drug regulators today.
  • Officials report 11–14 child deaths tied to suspected acute kidney injury in Chhindwara and related cases in Rajasthan, with patient samples sent to NIV Pune and some early non-Coldrif samples reported DEG-free.